We propose to develop an advanced rapid point of care diagnostic for HIV. This approach will leverage a novel D4 diagnostic assay platform: The D4 is so named because of the chain of events that occur upon addition of blood: (1) Dispense blood onto chip; (2) Dissolution of ?soluble? detection reagent spots (3) Diffusion of coated virion across a surface and binding to specific capture Ab spots; (4) Detection of binding with fluorescence imaging. We will enhance HIV virion capture using a lectin, Griffithsin, which can bind to the glycan shield of HIV virions spikes and induce exposure of CD4 binding sites which can be captured by antibodies. Individual virions can be captured, labelled and imaged using next generation cell phone based microscopy. This diagnostic test enables not only rapid ?window independent? diagnosis independent of patient antibodies, but also potentially for routine viral load monitoring.

Public Health Relevance

We propose to develop an advanced rapid point of care diagnostic for HIV. This diagnostic relies on labelling of the HIV glycan shield with a lectin, antibody capture and subsequent imaging of individual virions using cell phone microscopy. This assay is performed on a low-cost printed micro-spot chip. This approach is amenable to not only rapid HIV diagnosis but also routine viral load monitoring.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Project #
5R61AI140485-02
Application #
9977120
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Lawrence, Diane M
Project Start
2019-08-01
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Duke University
Department
Biomedical Engineering
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705